Friday, 10 Apr 2020

You are here

Similar Outcomes for Hip Arthroplasty or Hemiarthroplasty in Hip Fracture

The NEJM reports on a randomized comparison of hemiarthroplasty and total hip arthroplasty in displaced femoral neck fractures and shows no difference in function and quality of life over 24 months.

This Canadian, multicenter trial included 1495 patients, over age 50 years, who had a displaced femoral neck fracture to undergo either total hip arthroplasty or hemiarthroplasty. The primary end point was a secondary hip procedure within 24 months of follow-up.

The need for a secondary hip procedure was the same with total hip arthroplasty (7.9%) and hemiarthroplasty (8.3%)  (hazard ratio, 0.95; 95% confidence interval [CI], 0.64 to 1.40; P=0.79).

Hip instability or dislocation occurred in 4.7% and 2.4%, respectively. Function (measured by the WOMAC total score), pain score, stiffness score, and function score, modestly favored total hip arthroplasty over hemiarthroplasty.

Mortality over 24 months was similar (14.3% vs 13.1%) and serious adverse events were high but equal (41.8% vs. 36.7%). 

Despite a slight edge for total hip arthroplasty (over hemiarthroplasty) in function and quality of life over 24 months, the outcomes were the same regardless of surgical procedure chosen.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Tanezumab: A Win as Last-Ditch Osteoarthritis Tx

A phase III study of the nerve growth factor and monoclonal antibody tanezumab showed positive results in a refractory patient population with knee or hip osteoarthritis (OA) -- good enough that this agent may finally be approved after a long and rocky development road.

Diabetes in OA: Pain Is Worse

Among patients with knee osteoarthritis (OA), pain was greater for those with coexisting diabetes mellitus (DM), and this association was independent of obesity and radiographic severity, European researchers found. 

JAK Inhibitors Stimulate Osteoblasts

Science Translational Medicine has a report on how the use of Janus kinase (JAK) inhibitors may boost osteoblasts to battle bone erosions in conditions like rheumatoid arthritis (RA).

JAK inhibitors have been shown in clinical trials to retard the development of bone erosions while controlling RA inflammation and other clinical features.

Hormone Therapy for Postmenopausal Women

The NEJM weighs in on the problem of post-menopausal osteoporosis (OP) and tackles the use of hormonal therapy. The decline in estrogen after menopause may increase risks for osteoporosis, cardiovascular disease, and cognitive decline. The use of hormone replacement therapy (HRT) to obviate these issues may be primarily driven by hot flashes in postmenopausal women.1 Who may benefit from hormone therapy among postmenopausal women?

Knee Replacements Last 25 Years

UK registry reports that greater than 80% of total knee replacements can last for 25 years.

The outcomes regarding the duration and durability of knee arthroplasties is sketchy, with many orthopedists projecting a 15 to 20 year survivial. Hence the need for an appraisal of the data.